DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1527336 | Sjogren's Syndrome | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0751295 | Memory Loss | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0007965 | Chediak-Higashi Syndrome | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C3888004 | HERMANSKY-PUDLAK SYNDROME 5 | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0004364 | Autoimmune Diseases | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C2936904 | Opitz GBBB Syndrome, X-Linked | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1563705 | Nephrogenic Diabetes Insipidus, Type I | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C3203102 | Idiopathic pulmonary arterial hypertension | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0007137 | Squamous cell carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0036529 | Myocardial Diseases, Secondary | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1306459 | Primary malignant neoplasm | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006118 | Brain Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0038454 | Cerebrovascular accident | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0006826 | Malignant Neoplasms | PRG3 | 10394 | proteoglycan 3, pro eosinophil major basic protein 2 | Q9Y2Y8 |
C0027651 | Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0013264 | Muscular Dystrophy, Duchenne | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0678222 | Breast Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0376358 | Malignant neoplasm of prostate | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0006142 | Malignant neoplasm of breast | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0004096 | Asthma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0007131 | Non-Small Cell Lung Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1704272 | Benign Prostatic Hyperplasia | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0684249 | Carcinoma of lung | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0009402 | Colorectal Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0600139 | Prostate carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024